AnaptysBio, Inc. ANAB Biopharma Company — Other Nonoperating Income Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s biopharma company — other nonoperating income expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s biopharma company — other nonoperating income expense?
- AnaptysBio, Inc. (ANAB) reported biopharma company — other nonoperating income expense of -$1K in Q1 2026.
- How has AnaptysBio, Inc.'s biopharma company — other nonoperating income expense changed year-over-year?
- AnaptysBio, Inc.'s biopharma company — other nonoperating income expense increased by 85.7% year-over-year, from -$7K to -$1K.
- What does biopharma company — other nonoperating income expense mean?
- This metric captures miscellaneous income or expenses that are not directly related to the company's core biopharmaceutical operations. It includes items such as gains or losses on asset disposals, foreign exchange fluctuations, or other non-recurring financial events. It provides a view of peripheral financial impacts on the company's bottom line.